Polyphenol-Loaded Polymeric Matrixes as Potential Biopharmaceuticals against Cancer
Abstract
:1. Introduction
2. Materials and Methods
3. Anticancer Properties of Polyphenols
3.1. In Vivo Studies
Compound | Dose | Model | Effect | Reference |
---|---|---|---|---|
Caffeic acid | 50 nmol/kg | Mice with human colon cancer xenografts | Inhibition of tumor growth via downregulation of PI3K/Akt and MAPK/ERK signaling | [14] |
Caffeic acid phenylpropyl ester | 50 nmol/kg | Mice with human colon cancer xenografts | Inhibition of tumor growth via downregulation of PI3K/Akt and MAPK/ERK signaling | [14] |
Chlorogenic acid | 20–40 mg/kg | Mice with breast cancer xenografts | Decrease in tumor growth and inhibition of metastasis via an increase in CD4+ and CD8+ cells in the spleen | [18] |
Ellagic acid | 40 mg/kg | Mice with human bladder cancer xenografts | Decrease in tumor growth rate, infiltrative behavior, and tumor-associated angiogenesis. | [19] |
80 mg/kg | Mice with induced lymphoma | Induction of apoptosis via an increase in caspase-3 expression and activity and PKCs activity and a decrease in LDH-A activity and expression in ascites fluid | [8] | |
Eriodictyol | 60 mg/kg | Mice with mammary cancer xenografts | Decrease in tumor growth and progression and in lung metastasis | [11] |
Galangin | 25–50 mg/kg | Mice with human retinoblastoma xenografts | Decrease in tumor growth via a decrease in Akt signaling pathway and increase in caspase-3 level | [9] |
Luteolin | 1.2 mg/g | Mice with AOM/DMH-induced colon cancer | Decrease in LDH levels and in iNOS and COX-2 expression in colon tissue | [20] |
100 mg/kg | Mice with human epithelial xenograft | Decrease in migration and invasion | [12] | |
Naringenin | 50 mg/kg | Mice with benzo(a)pyrene induced lung cancer | Downregulation of CYP1A1, PCNA, and NF-κB expression; decrease in lipid peroxidation, TNF-α, IL-6 and IL-1β; increase in antioxidant enzymes activity in lung tissue | [16] |
Quercetin | 30 mg/kg | Mice with AOM/dextran sodium sulfate-induced colorectal cancer | Decrease in tumor growth and proliferation via a decrease in inflammation and ROS | [21] |
25–50 mg/kg | Rats with DMH-induced colon cancer | Decrease in tumor incidence and multiplicity; downregulation of the Wnt signaling pathway in colon tissue | [22] | |
Taxifolin | 4 µg/kg | Mice with DMH-induced colon cancer | Upregulation of the Nrf2 signaling pathway, downregulation of the NF-κB and Wnt signaling pathways in colon tissue | [17] |
1 mg/kg | Mice with human lung cancer xenograft | Decrease in tumor size via inhibition of PI3K and TCF4 signaling and by decreasing epithelial–mesenchymal transition | [13] | |
Vanillic acid | 75 mg/kg | Rats with DMH-induced hepatic cancer | Upregulation of the Nrf2 signaling pathway; induction of apoptosis via an increase in Bad and Caspase-3 genes expression and decrease in Bcl-2 gene expression; decrease in proliferation via a decrease in Cyclin D1 gene expression in hepatic tissue | [10] |
3.2. Clinical Studies
4. Polymeric Matrixes to Encapsulate Polyphenols
5. Studies with Polyphenol-Loaded Polymeric Matrixes with Anticancer Properties
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Quideau, S.; Deffieux, D.; Douat-Casassus, C.; Pouységu, L. Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis. Angew. Chem. Int. Ed. 2011, 50, 586–621. [Google Scholar] [CrossRef]
- Neveu, V.; Perez-Jiménez, J.; Vos, F.; Crespy, V.; du Chaffaut, L.; Mennen, L.; Knox, C.; Eisner, R.; Cruz, J.; Wishart, D.; et al. Phenol-Explorer: An online comprehensive database on polyphenol contents in foods. Database 2010, 2010, bap024. [Google Scholar] [CrossRef]
- Rothwell, J.A.; Perez-Jimenez, J.; Neveu, V.; Medina-Remón, A.; M’Hiri, N.; García-Lobato, P.; Manach, C.; Knox, C.; Eisner, R.; Wishart, D.S.; et al. Phenol-Explorer 3.0: A major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content. Database 2013, 2013, bat070. [Google Scholar] [CrossRef]
- Rothwell, J.A.; Urpi-Sarda, M.; Boto-Ordoñez, M.; Knox, C.; Llorach, R.; Eisner, R.; Cruz, J.; Neveu, V.; Wishart, D.; Manach, C.; et al. Phenol-Explorer 2.0: A major update of the Phenol-Explorer database integrating data on polyphenol metabolism and pharmacokinetics in humans and experimental animals. Database 2012, 2012, bas031. [Google Scholar] [CrossRef]
- Ferlay, J.; Ervik, M.; Lam, F.; Colombet, M.; Mery, L.; Piñeros, M.; Znaor, A.; Soerjomataram, I.; Bray, F. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer: Lyon, France. Available online: https://gco.iarc.fr/today (accessed on 11 May 2023).
- Chen, A.Y.; Chen, Y.C. A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem. 2013, 138, 2099–2107. [Google Scholar] [CrossRef] [Green Version]
- Naksuriya, O.; Okonogi, S.; Schiffelers, R.M.; Hennink, W.E. Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials 2014, 35, 3365–3383. [Google Scholar] [CrossRef] [PubMed]
- Mishra, S.; Vinayak, M. Ellagic Acid Induces Novel and Atypical PKC Isoforms and Promotes Caspase-3 Dependent Apoptosis by Blocking Energy Metabolism. Nutr. Cancer 2014, 66, 675–681. [Google Scholar] [CrossRef] [PubMed]
- Zou, W.-W.; Xu, S.-P. Galangin inhibits the cell progression and induces cell apoptosis through activating PTEN and Caspase-3 pathways in retinoblastoma. Biomed. Pharmacother. 2018, 97, 851–863. [Google Scholar] [CrossRef] [PubMed]
- Punvittayagul, C.; Chariyakornkul, A.; Jarukamjorn, K.; Wongpoomchai, R. Protective Role of Vanillic Acid against Diethylnitrosamine- and 1,2-Dimethylhydrazine-Induced Hepatocarcinogenesis in Rats. Molecules 2021, 26, 2718. [Google Scholar] [CrossRef]
- Debnath, S.; Sarkar, A.; Mukherjee, D.D.; Ray, S.; Mahata, B.; Mahata, T.; Parida, P.K.; Das, T.; Mukhopadhyay, R.; Ghosh, Z.; et al. Eriodictyol mediated selective targeting of the TNFR1/FADD/TRADD axis in cancer cells induce apoptosis and inhibit tumor progression and metastasis. Transl. Oncol. 2022, 21, 101433. [Google Scholar] [CrossRef]
- Yao, Y.; Rao, C.; Zheng, G.; Wang, S. Luteolin suppresses colorectal cancer cell metastasis via regulation of the miR-384/pleiotrophin axis. Oncol. Rep. 2019, 42, 131–141. [Google Scholar] [CrossRef]
- Wang, R.; Zhu, X.; Wang, Q.; Li, X.; Wang, E.; Zhao, Q.; Wang, Q.; Cao, H. The anti-tumor effect of taxifolin on lung cancer via suppressing stemness and epithelial-mesenchymal transition in vitro and oncogenesis in nude mice. Ann. Transl. Med. 2020, 8, 590. [Google Scholar] [CrossRef] [PubMed]
- Chiang, E.-P.I.; Tsai, S.-Y.; Kuo, Y.-H.; Pai, M.-H.; Chiu, H.-L.; Rodriguez, R.L.; Tang, F.-Y. Caffeic Acid Derivatives Inhibit the Growth of Colon Cancer: Involvement of the PI3-K/Akt and AMPK Signaling Pathways. PLoS ONE 2014, 9, e99631. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vaidya, F.U.; Chhipa, A.S.; Sagar, N.; Pathak, C. Oxidative Stress and Inflammation Can Fuel Cancer; Springer: Singapore, 2020; pp. 229–258. [Google Scholar]
- Bodduluru, L.N.; Kasala, E.R.; Madhana, R.M.; Barua, C.C.; Hussain, M.I.; Haloi, P.; Borah, P. Naringenin ameliorates inflammation and cell proliferation in benzo(a)pyrene induced pulmonary carcinogenesis by modulating CYP1A1, NFκB and PCNA expression. Int. Immunopharmacol. 2016, 30, 102–110. [Google Scholar] [CrossRef] [PubMed]
- Manigandan, K.; Manimaran, D.; Jayaraj, R.L.; Elangovan, N.; Dhivya, V.; Kaphle, A. Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis. Biochimie 2015, 119, 103–112. [Google Scholar] [CrossRef]
- Zeng, A.; Liang, X.; Zhu, S.; Liu, C.; Wang, S.; Zhang, Q.; Zhao, J.; Song, L. Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF-κB signaling pathway. Oncol. Rep. 2020, 45, 717–727. [Google Scholar] [CrossRef]
- Ceci, C.; Tentori, L.; Atzori, M.; Lacal, P.; Bonanno, E.; Scimeca, M.; Cicconi, R.; Mattei, M.; De Martino, M.; Vespasiani, G.; et al. Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth. Nutrients 2016, 8, 744. [Google Scholar] [CrossRef] [Green Version]
- Pandurangan, A.K.; Sadagopan, S.K.A.; Dharmalingam, P.; Ganapasam, S. Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: Involvement of iNOS and COX-2. Pharmacogn. Mag. 2014, 10, 306–310. [Google Scholar] [CrossRef] [Green Version]
- Lin, R.; Piao, M.; Song, Y.; Liu, C. Quercetin Suppresses AOM/DSS-Induced Colon Carcinogenesis through Its Anti-Inflammation Effects in Mice. J. Immunol. Res. 2020, 2020, 9242601. [Google Scholar] [CrossRef]
- Shree, A.; Islam, J.; Sultana, S. Quercetin ameliorates reactive oxygen species generation, inflammation, mucus depletion, goblet disintegration, and tumor multiplicity in colon cancer: Probable role of adenomatous polyposis coli, β-catenin. Phytother. Res. 2021, 35, 2171–2184. [Google Scholar] [CrossRef]
- Feng, X.-L.; Zhan, X.-X.; Zuo, L.-S.-Y.; Mo, X.-F.; Zhang, X.; Liu, K.-Y.; Li, L.; Zhang, C.-X. Associations between serum concentration of flavonoids and breast cancer risk among Chinese women. Eur. J. Nutr. 2021, 60, 1347–1362. [Google Scholar] [CrossRef] [PubMed]
- Mérida-Ortega, Á.; Hernández-Alcaraz, C.; Hernández-Ramírez, R.U.; García-Martínez, A.; Trejo-Valdivia, B.; Salinas-Rodríguez, A.; Svensson, K.; Cebrián, M.E.; Franco-Marina, F.; López-Carrillo, L. Phthalate exposure, flavonoid consumption and breast cancer risk among Mexican women. Environ. Int. 2016, 96, 167–172. [Google Scholar] [CrossRef] [PubMed]
- Russo, G.; Campisi, D.; Di Mauro, M.; Regis, F.; Reale, G.; Marranzano, M.; Ragusa, R.; Solinas, T.; Madonia, M.; Cimino, S.; et al. Dietary Consumption of Phenolic Acids and Prostate Cancer: A Case-Control Study in Sicily, Southern Italy. Molecules 2017, 22, 2159. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zamora-Ros, R.; Sacerdote, C.; Ricceri, F.; Weiderpass, E.; Roswall, N.; Buckland, G.; St-Jules, D.E.; Overvad, K.; Kyrø, C.; Fagherazzi, G.; et al. Flavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br. J. Cancer 2014, 111, 1870–1880. [Google Scholar] [CrossRef] [Green Version]
- Zamora-Ros, R.; Cayssials, V.; Franceschi, S.; Kyrø, C.; Weiderpass, E.; Hennings, J.; Sandström, M.; Tjønneland, A.; Olsen, A.; Overvad, K.; et al. Polyphenol intake and differentiated thyroid cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int. J. Cancer 2020, 146, 1841–1850. [Google Scholar] [CrossRef]
- Nimptsch, K.; Zhang, X.H.; Cassidy, A.; Song, M.Y.; O’Reilly, E.J.; Lin, J.H.; Pischon, T.; Rimm, E.B.; Willett, W.C.; Fuchs, C.S.; et al. Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts. Am. J. Clin. Nutr. 2016, 103, 184–191. [Google Scholar] [CrossRef] [Green Version]
- Zamora-Ros, R.; Barupal, D.K.; Rothwell, J.A.; Jenab, M.; Fedirko, V.; Romieu, I.; Aleksandrova, K.; Overvad, K.; Kyrø, C.; Tjønneland, A.; et al. Dietary flavonoid intake and colorectal cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort. Int. J. Cancer 2017, 140, 1836–1844. [Google Scholar] [CrossRef] [Green Version]
- Londoño, C.; Cayssials, V.; De Villasante, I.; Crous-Bou, M.; Scalbert, A.; Weiderpass, E.; Agudo, A.; Tjønneland, A.; Olsen, A.; Overvad, K.; et al. Polyphenol Intake and Epithelial Ovarian Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Antioxidants 2021, 10, 1249. [Google Scholar] [CrossRef]
- Molina-Montes, E.; Sánchez, M.J.; Zamora-Ros, R.; Bueno-De-Mesquita, H.B.; Wark, P.A.; Obon-Santacana, M.; Kühn, T.; Katzke, V.; Travis, R.C.; Ye, W.; et al. Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Int. J. Cancer 2016, 139, 1480–1492. [Google Scholar] [CrossRef]
- Bahrami, A.; Jafari, S.; Rafiei, P.; Beigrezaei, S.; Sadeghi, A.; Hekmatdoost, A.; Rashidkhani, B.; Hejazi, E. Dietary intake of polyphenols and risk of colorectal cancer and adenoma–A case-control study from Iran. Complement. Ther. Med. 2019, 45, 269–274. [Google Scholar] [CrossRef]
- Zhou, Y.; Gu, K.; Zhou, F. Dietary Flavonoid Intake and Cancer Mortality: A Population-Based Cohort Study. Nutrients 2023, 15, 976. [Google Scholar] [CrossRef] [PubMed]
- Basak, S.K.; Bera, A.; Yoon, A.J.; Morselli, M.; Jeong, C.; Tosevska, A.; Dong, T.S.; Eklund, M.; Russ, E.; Nasser, H.; et al. A randomized, phase 1, placebo-controlled trial of APG-157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor-associated microbes. Cancer 2020, 126, 1668–1682. [Google Scholar] [CrossRef] [PubMed]
- Cruz-Correa, M.; Hylind, L.M.; Marrero, J.H.; Zahurak, M.L.; Murray-Stewart, T.; Casero, R.A.; Montgomery, E.A.; Iacobuzio-Donahue, C.; Brosens, L.A.; Offerhaus, G.J.; et al. Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis. Gastroenterology 2018, 155, 668–673. [Google Scholar] [CrossRef]
- Zhang, Z.; Garzotto, M.; Beer, T.M.; Thuillier, P.; Lieberman, S.; Mori, M.; Stoller, W.A.; Farris, P.E.; Shannon, J. Effects of ω-3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled Trial. Nutr. Cancer 2016, 68, 1309–1319. [Google Scholar] [CrossRef] [Green Version]
- Sinicrope, F.A.; Viggiano, T.R.; Buttar, N.S.; Song, L.M.W.K.; Schroeder, K.W.; Kraichely, R.E.; Larson, M.V.; Sedlack, R.E.; Kisiel, J.B.; Gostout, C.J.; et al. Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia. Cancer Prev. Res. 2021, 14, 573–580. [Google Scholar] [CrossRef] [PubMed]
- Student, V.; Vidlar, A.; Bouchal, J.; Vrbkova, J.; Kolar, Z.; Kral, M.; Kosina, P.; Vostalova, J. Cranberry intervention in patients with prostate cancer prior to radical prostatectomy. Clinical, pathological and laboratory findings. Biomed. Pap. 2016, 160, 559–565. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Citronberg, J.; Bostick, R.; Ahearn, T.; Turgeon, D.K.; Ruffin, M.T.; Djuric, Z.; Sen, A.; Brenner, D.E.; Zick, S.M. Effects of Ginger Supplementation on Cell-Cycle Biomarkers in the Normal-Appearing Colonic Mucosa of Patients at Increased Risk for Colorectal Cancer: Results from a Pilot, Randomized, and Controlled Trial. Cancer Prev. Res. 2013, 6, 271–281. [Google Scholar] [CrossRef] [Green Version]
- Messing, E.; Gee, J.R.; Saltzstein, D.R.; Kim, K.; Disant’Agnese, A.; Kolesar, J.; Harris, L.; Faerber, A.; Havighurst, T.; Young, J.M.; et al. A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Presurgical Bladder Cancer Patients. Cancer Prev. Res. 2012, 5, 621–630. [Google Scholar] [CrossRef] [Green Version]
- Pilvenyte, G.; Ratautaite, V.; Boguzaite, R.; Ramanavicius, A.; Viter, R.; Ramanavicius, S. Molecularly Imprinted Polymers for the Determination of Cancer Biomarkers. Int. J. Mol. Sci. 2023, 24, 4105. [Google Scholar] [CrossRef]
- Yin, Z.; Zheng, T.; Ho, C.-T.; Huang, Q.; Wu, Q.; Zhang, M. Improving the stability and bioavailability of tea polyphenols by encapsulations: A review. Food Sci. Hum. Wellness 2022, 11, 537–556. [Google Scholar] [CrossRef]
- Garcia-Carrasco, M.; Picos-Corrales, L.A.; Gutiérrez-Grijalva, E.P.; Angulo-Escalante, M.A.; Licea-Claverie, A.; Heredia, J.B. Loading and Release of Phenolic Compounds Present in Mexican Oregano (Lippia graveolens) in Different Chitosan Bio-Polymeric Cationic Matrixes. Polymers 2022, 14, 3609. [Google Scholar] [CrossRef] [PubMed]
- Pimentel-Moral, S.; Teixeira, M.C.; Fernandes, A.R.; Arráez-Román, D.; Martínez-Férez, A.; Segura-Carretero, A.; Souto, E.B. Lipid nanocarriers for the loading of polyphenols—A comprehensive review. Adv. Colloid Interface Sci. 2018, 260, 85–94. [Google Scholar] [CrossRef] [PubMed]
- Manzanares-Guevara, L.A.; Licea-Claverie, A.; Oroz-Parra, I.; Bernaldez-Sarabia, J.; Diaz-Castillo, F.; Licea-Navarro, A.F. Smart Nanoformulation Based on Stimuli-Responsive Nanogels and Curcumin: Promising Therapy against Colon Cancer. ACS Omega 2020, 5, 9171–9184. [Google Scholar] [CrossRef] [Green Version]
- Hu, B.; Liu, X.; Zhang, C.; Zeng, X. Food macromolecule based nanodelivery systems for enhancing the bioavailability of polyphenols. J. Food Drug Anal. 2017, 25, 3–15. [Google Scholar] [CrossRef]
- Tang, H.-Y.; Fang, Z.; Ng, K. Dietary fiber-based colon-targeted delivery systems for polyphenols. Trends Food Sci. Technol. 2020, 100, 333–348. [Google Scholar] [CrossRef]
- Song, J.; Feng, H.; Wu, M.; Chen, L.; Xia, W.; Zhang, W. Development of a bioactive chitosan HPMC-based membrane with tea polyphenols encapsulated in β-cyclodextrin as an effective enhancement. Mater. Today Commun. 2021, 27, 102324. [Google Scholar] [CrossRef]
- Zhang, X.; Wang, C.; Qi, Z.; Zhao, R.; Wang, C.; Zhang, T. Pea protein based nanocarriers for lipophilic polyphenols: Spectroscopic analysis, characterization, chemical stability, antioxidant and molecular docking. Food Res. Int. 2022, 160, 111713. [Google Scholar] [CrossRef]
- Cheng, H.; Fang, Z.; Wusigale; Bakry, A.M.; Chen, Y.; Liang, L. Complexation of trans- and cis-resveratrol with bovine serum albumin, β-lactoglobulin or α-lactalbumin. Food Hydrocoll. 2018, 81, 242–252. [Google Scholar] [CrossRef]
- Costa, M.; Sezgin-Bayindir, Z.; Losada-Barreiro, S.; Paiva-Martins, F.; Saso, L.; Bravo-Díaz, C. Polyphenols as Antioxidants for Extending Food Shelf-Life and in the Prevention of Health Diseases: Encapsulation and Interfacial Phenomena. Biomedicines 2021, 9, 1909. [Google Scholar] [CrossRef]
- López de Dicastillo, C.; Piña, C.; Garrido, L.; Arancibia, C.; Galotto, M.J. Enhancing Thermal Stability and Bioaccesibility of Açaí Fruit Polyphenols through Electrohydrodynamic Encapsulation into Zein Electrosprayed Particles. Antioxidants 2019, 8, 464. [Google Scholar] [CrossRef] [Green Version]
- Dai, Q.; Geng, H.; Yu, Q.; Hao, J.; Cui, J. Polyphenol-Based Particles for Theranostics. Theranostics 2019, 9, 3170–3190. [Google Scholar] [CrossRef] [PubMed]
- Brito, J.; Hlushko, H.; Abbott, A.; Aliakseyeu, A.; Hlushko, R.; Sukhishvili, S.A. Integrating Antioxidant Functionality into Polymer Materials: Fundamentals, Strategies, and Applications. ACS Appl. Mater. Interfaces 2021, 13, 41372–41395. [Google Scholar] [CrossRef] [PubMed]
- Rahaiee, S.; Assadpour, E.; Faridi Esfanjani, A.; Silva, A.S.; Jafari, S.M. Application of nano/microencapsulated phenolic compounds against cancer. Adv. Colloid Interface Sci. 2020, 279, 102153. [Google Scholar] [CrossRef] [PubMed]
- Piazzini, V.; Vasarri, M.; Degl’Innocenti, D.; Guastini, A.; Barletta, E.; Salvatici, M.C.; Bergonzi, M.C. Comparison of Chitosan Nanoparticles and Soluplus Micelles to Optimize the Bioactivity of Posidonia oceanica Extract on Human Neuroblastoma Cell Migration. Pharmaceutics 2019, 11, 655. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mostafa, M.M.; Amin, M.M.; Zakaria, M.Y.; Hussein, M.A.; Shamaa, M.M.; Abd El-Halim, S.M. Chitosan Surface-Modified PLGA Nanoparticles Loaded with Cranberry Powder Extract as a Potential Oral Delivery Platform for Targeting Colon Cancer Cells. Pharmaceutics 2023, 15, 606. [Google Scholar] [CrossRef]
- Choi, S.M.; Pham, V.C.; Lee, S.; Kim, J.A. Metabolism of Diterpenoids Derived from the Bark of Cinnamomum cassia in Human Liver Microsomes. Pharmaceutics 2021, 13, 1316. [Google Scholar] [CrossRef]
- Atallah, M.A.; Sallam, M.A.; Abdelmoneem, M.A.; Teleb, M.; Elkhodairy, K.A.; Bekhit, A.A.; Khafaga, A.F.; Noreldin, A.E.; Elzoghby, A.O.; Khattab, S.N. Green self-assembled lactoferrin carboxymethyl cellulose nanogels for synergistic chemo/herbal breast cancer therapy. Colloids Surf. B Biointerfaces 2022, 217, 112657. [Google Scholar] [CrossRef]
- Levit, S.L.; Yang, H.; Tang, C. Rapid Self-Assembly of Polymer Nanoparticles for Synergistic Codelivery of Paclitaxel and Lapatinib via Flash NanoPrecipitation. Nanomaterials 2020, 10, 561. [Google Scholar] [CrossRef] [Green Version]
- Hong, S.; Dia, V.P.; Baek, S.J.; Zhong, Q. Nanoencapsulation of apigenin with whey protein isolate: Physicochemical properties, in vitro activity against colorectal cancer cells, and bioavailability. LWT 2022, 154, 112751. [Google Scholar] [CrossRef]
- Suárez-García, S.; Esposito, T.V.F.; Neufeld-Peters, J.; Bergamo, M.; Yang, H.; Saatchi, K.; Schaffer, P.; Häfeli, U.O.; Ruiz-Molina, D.; Rodríguez-Rodríguez, C.; et al. Hybrid Metal–Phenol Nanoparticles with Polydopamine-like Coating for PET/SPECT/CT Imaging. ACS Appl. Mater. Interfaces 2021, 13, 10705–10718. [Google Scholar] [CrossRef] [PubMed]
- Aljabali, A.A.A.; Bakshi, H.A.; Hakkim, F.L.; Haggag, Y.A.; Al-Batanyeh, K.M.; Al Zoubi, M.S.; Al-Trad, B.; Nasef, M.M.; Satija, S.; Mehta, M.; et al. Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1α. Cancers 2020, 12, 113. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ghayour, N.; Hosseini, S.M.H.; Eskandari, M.H.; Esteghlal, S.; Nekoei, A.-R.; Hashemi Gahruie, H.; Tatar, M.; Naghibalhossaini, F. Nanoencapsulation of quercetin and curcumin in casein-based delivery systems. Food Hydrocoll. 2019, 87, 394–403. [Google Scholar] [CrossRef]
- Peñalva, R.; Morales, J.; González-Navarro, C.J.; Larrañeta, E.; Quincoces, G.; Peñuelas, I.; Irache, J.M. Increased Oral Bioavailability of Resveratrol by Its Encapsulation in Casein Nanoparticles. Int. J. Mol. Sci. 2018, 19, 2816. [Google Scholar] [CrossRef] [Green Version]
- Mendez-Pfeiffer, P.; Juarez, J.; Hernandez, J.; Taboada, P.; Virués, C.; Alday, E.; Valencia, D.; Velazquez, C. Polymeric nanoparticles for the delivery of Sonoran desert propolis: Synthesis, characterization and antiproliferative activity on cancer cells. Colloids Surf. B: Biointerfaces 2022, 215, 112475. [Google Scholar] [CrossRef] [PubMed]
- Ahmed, R.; Tariq, M.; Ahmad, I.S.; Fouly, H.; Fakhari, A.; Hasan, A.; Kushad, M. Poly(lactic-co<-glycolic acid) Nanoparticles Loaded with Callistemon citrinus Phenolics Exhibited Anticancer Properties against Three Breast Cancer Cell Lines. J. Food Qual. 2019, 2019, 2638481. [Google Scholar] [CrossRef] [Green Version]
- Sankaran, V.; Murali, S.K.; Ghidan, A.; Antary, T.A.; David, E. Oral cancer preventive potential of Polydatin: A nanoencapsulation approach. J. Phytol. 2020, 12, 109–116. [Google Scholar] [CrossRef]
- Han, Y.; Dong, Z.; Wang, C.; Li, Q.; Hao, Y.; Yang, Z.; Zhu, W.; Zhang, Y.; Liu, Z.; Feng, L. Ferrous ions doped calcium carbonate nanoparticles potentiate chemotherapy by inducing ferroptosis. J. Control. Release 2022, 348, 346–356. [Google Scholar] [CrossRef]
- Ma, Z.; Gao, X.; Raza, F.; Zafar, H.; Huang, G.; Yang, Y.; Shi, F.; Wang, D.; He, X. Design of GSH-Responsive Curcumin Nanomicelles for Oesophageal Cancer Therapy. Pharmaceutics 2022, 14, 1802. [Google Scholar] [CrossRef]
- Yadav, K.; Bajaj, R.K.; Mandal, S.; Mann, B. Encapsulation of grape seed extract phenolics using whey protein concentrate, maltodextrin and gum arabica blends. J. Food Sci. Technol. 2020, 57, 426–434. [Google Scholar] [CrossRef]
- Parashar, P.; Rathor, M.; Dwivedi, M.; Saraf, S.A. Hyaluronic Acid Decorated Naringenin Nanoparticles: Appraisal of Chemopreventive and Curative Potential for Lung Cancer. Pharmaceutics 2018, 10, 33. [Google Scholar] [CrossRef] [Green Version]
- Pudziuvelyte, L.; Marksa, M.; Sosnowska, K.; Winnicka, K.; Morkuniene, R.; Bernatoniene, J. Freeze-Drying Technique for Microencapsulation of Elsholtzia ciliata Ethanolic Extract Using Different Coating Materials. Molecules 2020, 25, 2237. [Google Scholar] [CrossRef]
- Hussain, S.A.; Hameed, A.; Nazir, Y.; Naz, T.; Wu, Y.; Suleria, H.A.; Song, Y. Microencapsulation and the Characterization of Polyherbal Formulation (PHF) Rich in Natural Polyphenolic Compounds. Nutrients 2018, 10, 843. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ralaivao, M.; Lucas, J.; Rocha, F.; Estevinho, B.N. Food-Grade Microencapsulation Systems to Improve Protection of the Epigallocatechin Gallate. Foods 2022, 11, 1990. [Google Scholar] [CrossRef] [PubMed]
- Bannikova, A.; Zyainitdinov, D.; Evteev, A.; Drevko, Y.; Evdokimov, I. Microencapsulation of polyphenols and xylooligosaccharides from oat bran in whey protein-maltodextrin complex coacervates: In-vitro evaluation and controlled release. Bioact. Carbohydr. Diet. Fibre 2020, 23, 100236. [Google Scholar] [CrossRef]
- Lee, Y.-K.; Chang, Y.H. Microencapsulation of a maca leaf polyphenol extract in mixture of maltodextrin and neutral polysaccharides extracted from maca roots. Int. J. Biol. Macromol. 2020, 150, 546–558. [Google Scholar] [CrossRef]
- Fathi, F.; Ebrahimi, S.N.; Pereira, D.M.; Estevinho, B.N.; Rocha, F. Preliminary studies of microencapsulation and anticancer activity of polyphenols extract from Punica granatum peels. Can. J. Chem. Eng. 2022, 100, 3240–3252. [Google Scholar] [CrossRef]
- Farrag, A.; El-Messery, T.M.; El-Said, M.M.; Soliman, T.N.; El-Din, H.M.F. Research Article Microencapsulation of Grape Phenolic Compounds Using Whey Proteins as a Carrier Vehicle. J. Biol. Sci. 2018, 18, 373–380. [Google Scholar] [CrossRef] [Green Version]
- Benito, I.; Encío, I.J.; Milagro, F.I.; Alfaro, M.; Martínez-Peñuela, A.; Barajas, M.; Marzo, F. Microencapsulated Bifidobacterium bifidum and Lactobacillus gasseri in Combination with Quercetin Inhibit Colorectal Cancer Development in ApcMin/+ Mice. Int. J. Mol. Sci. 2021, 22, 4906. [Google Scholar] [CrossRef] [PubMed]
- Tavakoli, F.; Jahanban-Esfahlan, R.; Seidi, K.; Jabbari, M.; Behzadi, R.; Pilehvar-Soltanahmadi, Y.; Zarghami, N. Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model. Artif. Cells Nanomed. Biotechnol. 2018, 46, 75–86. [Google Scholar] [CrossRef] [Green Version]
- Krishnan, G.; Subramaniyan, J.; Chengalvarayan Subramani, P.; Muralidharan, B.; Thiruvengadam, D. Hesperetin conjugated PEGylated gold nanoparticles exploring the potential role in anti-inflammation and anti-proliferation during diethylnitrosamine-induced hepatocarcinogenesis in rats. Asian J. Pharm. Sci. 2017, 12, 442–455. [Google Scholar] [CrossRef]
- Khan, I.; Sarkar, B.; Joshi, G.; Nakhate, K.T.; Ajazuddin; Mantha, A.K.; Kumar, R.; Kaul, A.; Chaturvedi, S.; Mishra, A.K.; et al. Biodegradable nanoparticulate co-delivery of flavonoid and doxorubicin: Mechanistic exploration and evaluation of anticancer effect in vitro and in vivo. Biomater. Biosyst. 2021, 3, 100022. [Google Scholar] [CrossRef]
- Das, S.; Das, J.; Samadder, A.; Paul, A.; Khuda-Bukhsh, A.R. Efficacy of PLGA-loaded apigenin nanoparticles in Benzo[a]pyrene and ultraviolet-B induced skin cancer of mice: Mitochondria mediated apoptotic signalling cascades. Food Chem. Toxicol. 2013, 62, 670–680. [Google Scholar] [CrossRef] [PubMed]
- Siddiqui, I.A.; Bharali, D.J.; Nihal, M.; Adhami, V.M.; Khan, N.; Chamcheu, J.C.; Khan, M.I.; Shabana, S.; Mousa, S.A.; Mukhtar, H. Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo. Nanomed. Nanotechnol. Biol. Med. 2014, 10, 1619–1626. [Google Scholar] [CrossRef] [PubMed]
- Arora, R.; Samim, M. Evaluation of anti-inflammatory and anti-cancer activity of calcium phosphate encapsulated Resveratrol in mouse skin cancer model. Biomed. Pharmacol. J. 2021, 14, 113–122. [Google Scholar] [CrossRef]
- Baksi, R.; Singh, D.P.; Borse, S.P.; Rana, R.; Sharma, V.; Nivsarkar, M. In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles. Biomed. Pharmacother. 2018, 106, 1513–1526. [Google Scholar] [CrossRef] [PubMed]
- Eskandari, Z.; Bahadori, F.; Yenigun, V.B.; Demiray, M.; Eroğlu, M.S.; Kocyigit, A.; Oner, E.T. Levan enhanced the NF-κB suppression activity of an oral nano PLGA-curcumin formulation in breast cancer treatment. Int. J. Biol. Macromol. 2021, 189, 223–231. [Google Scholar] [CrossRef]
- Song, Y.Y.; Yuan, Y.; Shi, X.; Che, Y.Y. Improved drug delivery and anti-tumor efficacy of combinatorial liposomal formulation of genistein and plumbagin by targeting Glut1 and Akt3 proteins in mice bearing prostate tumor. Colloids Surf. B Biointerfaces 2020, 190, 110966. [Google Scholar] [CrossRef] [PubMed]
- Huo, M.; Wang, H.; Zhang, Y.; Cai, H.; Zhang, P.; Li, L.; Zhou, J.; Yin, T. Co-delivery of silybin and paclitaxel by dextran-based nanoparticles for effective anti-tumor treatment through chemotherapy sensitization and microenvironment modulation. J. Control. Release 2020, 321, 198–210. [Google Scholar] [CrossRef] [PubMed]
- Chen, S.; Fan, J.X.; Zheng, D.W.; Liu, F.; Zeng, X.; Yan, G.P.; Zhang, X.Z. A multi-functional drug delivery system based on polyphenols for efficient tumor inhibition and metastasis prevention. Biomater. Sci. 2020, 8, 702–711. [Google Scholar] [CrossRef] [PubMed]
Compound(s) | Cancer Type | Population | Subjects (Age) | Effect | Reference |
---|---|---|---|---|---|
Flavonols and lignans | Bladder | 477,312 European subjects | 35–70 years | Inverse association between flavonols and lignans intake and bladder cancer risk | [26] |
Flavonols, isorhamnetin, kaempferol, flavanones and naringenin | Breast | 877 Chinese women with breast cancer, 792 control subjects | 25–70 years | The concentration of the flavonoids in the serum was associated with a lower breast cancer risk | [23] |
Anthocyanidins and flavan-3-ols | Breast | 233 Mexican women with breast cancer, 221 control subjects | >18 (mean 53) years | Higher intake of flavonoids reduced the risk of breast cancer, synergistically working with butyl benzyl phthalate | [24] |
Flavonols, flavones, flavanones, flavan-3-ols, and anthocyanins | Colorectal | 51,528 US male health professionals and 121,701 US female nurses | Men: 40–75 years Women: 30–55 years | No decrease in colorectal cancer was detected | [28] |
Flavonoids | Colorectal | 521,448 European subjects (with exceptions) | 35–70 years | No association between flavonoids intake and colorectal cancer was found | [29] |
Phenolic acids, hydroxycinnamic acids, flavonols, and stilbenes | Colorectal and colorectal adenoma | 129 Iranian subjects with colorectal cancer, 130 with colorectal adenoma, and 240 controls | 30–79 years | Higher intake of phenolic acids, hydroxycinnamic acids, and flavonols was associated with a decrease in colorectal cancer risk. Higher intake of stilbenes was associated with a lower colorectal adenoma risk. | [32] |
Polyphenols | Epithelial ovarian cancer | 309,129 European women | 35–70 years | No association between polyphenols intake and endothelial ovarian cancer was found | [30] |
Naringenin, peonidin, and catechin | General | 14,029 US subjects | >18 | Inverse association between flavonoids intake and cancer mortality | [33] |
Flavonoids and lignans | Pancreatic | 477,309 European subjects | 25–70 years | No association between flavonoids and lignans intake and pancreatic cancer was found | [31] |
Caffeic acid and ferulic acid | Prostate | 118 Italian prostate cancer subjects, 22 controls | Mean age: 69.13 years | High intake of phenolic acids may be associated with a decrease in prostate cancer risk | [25] |
Polyphenols and phenolic acids | Thyroid | 476,108 European subjects | 35–70 years | Inverse association between polyphenols and phenolic acids intake and thyroid cancer risk in patients with BMI ≥ 25 | [27] |
Cancer | Compound | Dose | Subjects | Effect | Reference |
---|---|---|---|---|---|
Bladder | Genistein | 300 or 600 mg | 59 subjects with urothelial bladder cancer | Inhibition of bladder cancer growth by inhibiting the phosphorylation of the epidermal growth factor receptor | [40] |
Colorectal | Ginger (Zingiber officinale) extract with 5% of gingerols | 2 g | 21 healthy subjects with a high risk of colorectal cancer | Decrease in the proliferation of crypts | [39] |
Epigallocatechin gallate | 780 mg | 32 subjects with rectal aberrant crypt foci | No difference in the number of the rectal aberrant crypt foci | [37] | |
Familial adenomatous polyposis | Curcumin | 3000 mg | 44 subjects with familial adenomatous polyposis | No difference in the mean number or size of polyps | [35] |
Oral | Curcuma longa phenolic extract | 100 or 200 mg | 12 oral cancer patients 13 normal subjects | Decrease in IL-1β, IL-6, and IL-8 content in the saliva. Increased gene expression related to differentiation and T cell recruitment to the tumor microenvironment. | [34] |
Prostate | Cranberry fruit powder | 1500 mg | 62 subjects with prostate cancer | Decrease in serum prostate-specific antigen | [38] |
Epigallocatechin gallate | 600 mg | 43 subjects with a prior negative biopsy, but suspicious | No difference in fatty acid synthase or antigen Ki-76 | [36] |
Encapsulated | Non-Encapsulated |
---|---|
| Ionization and/or loss of phenolic compounds throughout the gastrointestinal process Low solubility in aqueous medium, high solubility in organic media frequently unfit for human consumption. Decreased activity of polyphenolic compounds after the gastrointestinal process |
Wall Materials | Interaction | Technique of Encapsulation | Phenolic Compound | Application | Reference |
---|---|---|---|---|---|
Chitosan–PEGMA Chitosan | Hydrogen bond | Desolvation method Nanoemulsion | Lippia graveolens (ethanolic extract) Posidonia oceanica extract | - Inhibitory activity against neuroblastoma cell migration. | [43,56] |
Chitosan–poly (d,l-lactide-co-glycolide) | Hydrogen bond | Double emulsion solvent evaporation | Cranberry powder extracts | Cytotoxicity of colon cancer cells (HT-29) | [57] |
β-Cyclodextrin | Hydrogen bond | Coacervation Desolvation method | Curcumin Resveratrol and Oxyresveratrol | Transdermal delivery (melanoma treatment) Antiproliferative effect in prostate cancer cells | [58] |
Carboxymethyl cellulose–lactoferrin | Hydrogen bond | Desolvation method | Hidroxypropyl-beta-cyclodetrin–Polyphenol honokiol | Inhibition of tumor growth in in vivo studies (EAT) | [59] |
α-tocopherol and polystyrene block–polyethylene glycol | Covalent and chelation | Flash nanoprecipitation | Tannic acid, Paclitaxel | Against OVCA-432 ovarian cancer cells | [60,61] |
In(III) and Cu(III) | Covalent | Catechol 3,4-dihydroxycinnamic | Contrast Agent | [62] | |
Albumin | Hydrogen bond | Desolvation method | Piceatannol | Down-regulation of p65 and HIF-1 (proteins associated with different types of cancer) | [63] |
Casein | Hydrogen bond | Desolvation method Coacervation (Spray drying) | Quercetin and Curcumin Resveratrol | Against MCF-7 breast cancer cells Increased bioavailability of resveratrol in plasma | [64,65] |
Whey protein | Hydrogen bond | pH-cycling treatment | Apigenin | Against colorectal cancer cells HTC-116 and HT-29 | [61] |
Poly-(lactide-co-glycolide) acid (PLGA) | Hydrogen bond | Nanoprecipitation Emulsion (O/W) | Sonoran desert propolis Callistemon citrinus Phenolics and berberine Polydatin | Antiproliferative activity Antiproliferative effect in breast cancer cells (MCF-7, MCF-10A, and MDA-MB 231) Decreasing lipid peroxidation activity in hamster induced with oral cancer | [66,67,68] |
PGFCaCO3-PEG | Chelation | - | Gallic acid | Suppressed 4T1 tumor growth | [69] |
Retinoic acids and hyaluronic acid | Hydrogen bond | Dialysis | Curcumin | Present sensibility to GSH and promote the liberation of curcumin in esophageal cancer cells (ECA-109) | [70] |
Soluplus | Hydrogen bond | Desolvation method | Posidonia oceanica Extract | Inhibitory activity against neuroblastoma cell migration | [56] |
Whey protein–maltodextrin/Arabic gum | Hydrogen bond | Coacervation | Grape seed extract | Combination of the different polymers improved microencapsulation | [71] |
Poly(ε-caprolactam)–hyaluronic acid | Hydrogen bond | Nanoprecipitation | Naringenin | Antiproliferation of lung cancer cells | [72] |
Wall Materials | Interaction | Technique of Encapsulation | Phenolic Compound | Application | References |
---|---|---|---|---|---|
Maltodextrin/modified chitosan/pectin | Hydrogen bond | Spay drying | Punica granatum peels extract | The cytotoxicity was improved when the extract was encapsulated in AGS (human gastric adenocarcinoma) and A549 (human lung carcinoma) cell lines | [78] |
Whey protein | Hydrogen bond | Emulsion | Grape Phenolic | After digestion, the activity of the polyphenols was stabilized | [79] |
Maltodextrin | Hydrogen bond | Spray drying | Grape phenolics | After digestion, the activity and the bioaccessibility of the polyphenols increased | [79] |
Sodium alginate | Hydrogen bond | Extrusion | Bifidobacterium bifidum and Lactobacillus gasseri in combination with quercetin | Combining probiotics and quercetin resulted in a more effective protection and prevented hepatomegaly. Mechanistically, the results suggested that microencapsulated probiotics in combination with quercetin could exert the inhibition of the canonical Wnt/β-catenin signaling pathway in the colon | [80] |
Wall Agent | Encapsulated Polyphenol | Treatment | Result | References |
---|---|---|---|---|
Chitosan, nanoencapsulation | Quercetin | C57BL6 mice used to examine anti-tumor activity. Tumors were induced in immunocompromised mice, using human xenografts obtained with A549 and MDA-MB-468 cells. Chitosan–quercetin nanoencapsulation increased superoxide dismutase activity in treated mice. | Tumor regression (62.86% and 49.96% volume reduction for A549 and MDA-MB-468 cells, respectively) was observed after treatment with chitosan-nanoencapsulated quercetin, as a better anticancer agent than quercetin alone. | [87] |
Whey protein isolate, nanoencapsulation | Apigenin | Male and female C57BL/6J mice were administered nanoencapsulated apigenin at 50 mg/kg | Chitosan nanoencapsulation of apigenin improved the latter’s bioavailability with respect to free apigenin. Nanoencapsulation improved the absorption of apigenin | [61] |
Poly(lactide-co-glycolide) and levan | Curcumin | The nanoformulation consisted of 10 mg of curcumin, 50 mg of poly(lactide-co-glycolide), and 80 mg of levan. Intraperitoneal administration of the formulation for 17 days | The nanoformulation of poly(lactide-co-glycolide) and levan with curcumin enhanced curcumin accumulation at the tumor site. The treatment also inhibited NF-kB. | [88] |
Liposomes | Plumbagin and genistein (10:1 ratio) | Xenografted tumors by subcutaneous injection of PC3 or LNCaP prostate cancer cells in female athymic nude mice. Liposomes (1.5 mg genistein/kg and 15 mg plumbagin/kg bodyweight) were administered intravenously for 18 days. | Treatment with genistein and plumbagin-loaded liposomes decreased by nearly 80% the tumor growth. | [89] |
Dextran–deoxycholic acid amphiphilic polymer | Silybin (co-encapsulated with paclitaxel) | Subcutaneous inoculation of A549 cells in BALB/c nude mice. The nanoencapsulated paclitaxel and silybin (7 mg/kg and 10 mg/kg bodyweight, respectively) were administered through the tail vein. | Co-encapsulated paclitaxel/silybin enhanced blood circulation from 1 to 5 h.Tthe improved blood circulation also enhanced the tumor accumulation of the compounds and caused tumor growth suppression | [90] |
Epigallocatechin-3-gallate–iron nanoparticles with doxorubicin | Epigallocatechin-3-gallate | Intravenous injection in 4T1 tumor-bearing BALB/c mice with epigallocatechin-3-gallate–iron nanoparticles with doxorubicin. | Treatment decreased tumor volume and caused necrosis in tumors, which was associated with tumor growth inhibition. | [91] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Picos-Salas, M.A.; García-Carrasco, M.; Heredia, J.B.; Cabanillas-Bojórquez, L.A.; Leyva-López, N.; Gutiérrez-Grijalva, E.P. Polyphenol-Loaded Polymeric Matrixes as Potential Biopharmaceuticals against Cancer. Macromol 2023, 3, 507-523. https://doi.org/10.3390/macromol3030030
Picos-Salas MA, García-Carrasco M, Heredia JB, Cabanillas-Bojórquez LA, Leyva-López N, Gutiérrez-Grijalva EP. Polyphenol-Loaded Polymeric Matrixes as Potential Biopharmaceuticals against Cancer. Macromol. 2023; 3(3):507-523. https://doi.org/10.3390/macromol3030030
Chicago/Turabian StylePicos-Salas, Manuel Adrian, Melissa García-Carrasco, José Basilio Heredia, Luis Angel Cabanillas-Bojórquez, Nayely Leyva-López, and Erick Paul Gutiérrez-Grijalva. 2023. "Polyphenol-Loaded Polymeric Matrixes as Potential Biopharmaceuticals against Cancer" Macromol 3, no. 3: 507-523. https://doi.org/10.3390/macromol3030030